Thomson Reuters Business Description
SkyePharma PLC is a drug delivery company developing oral and inhalation products. The principal activities of the Company included the research and development, manufacture and sale of prescription pharmaceutical products. The Company is engaged in the development and manufacture of pharmaceutical products based on information used internally by management to assess the performance of, and allocate resources to the business. The Company’s subsidiaries include SkyePharma Production SAS, SkyePharma (Jersey) Limited, Jago Holding AG, Jagotec AG, SkyePharma AG, SkyePharma Holding AG, SkyePharma Holding Inc. and SkyePharma US Inc.
